Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.805 USD | +6.34% | -12.72% | -30.08% |
05-08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.08% | 515M | |
+27.45% | 48.16B | |
-0.88% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.00% | 25.59B | |
-22.79% | 18.96B | |
+7.98% | 12.92B | |
+29.11% | 12.03B | |
-2.13% | 11.77B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- Canaccord Genuity Assumes Olema Pharmaceuticals Inc at Buy with $16 Price Target